NBIS vs UNH: Which Is the Better Buy?
Side-by-side comparison of Nebius Group N.V. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
Nebius Group N.V. · Technology
$218.99
+11.9% upside to fair value
Med Conviction
Grade C+
VS
UnitedHealth Group Incorporated · Healthcare
$423.38
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NBIS |
UNH |
| Current Price |
$218.99 |
$423.38 |
| Fair Value Estimate |
$245.00 |
$613.90 |
| Upside to Fair Value |
+11.9%
|
+45.0%
|
| Market Cap |
$52.6B |
$384.5B |
| Forward P/E |
—
|
27.2x
|
| EV / EBITDA |
—
|
13.8x
|
| Price / Sales |
59.9x
|
0.8x
|
| Price / FCF |
—
|
19.6x
|
| Revenue Growth YoY |
+684.0%
|
+0.4%
|
| Gross Margin |
48.0%
|
18.8%
|
| Operating Margin |
-68.8%
|
4.2%
|
| Return on Equity |
—
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
-4.7%
|
5.12%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Nebius Group is a fast-scaling neocloud GPU infrastructure provider spun out of Yandex's international assets, positioned at the center of the AI compute buildout with a validated capital relationship to Nvidia, which holds a 9.3% stake following a $2 billion investment. Revenue grew 684% year over year in Q1 2026 to $399 million, core AI cloud ARR reached $1.92 billion, and the company has locke…
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
Accumulation Zones
| Metric |
NBIS |
UNH |
| Zone Low |
$184.00 |
$460.42 |
| Zone High |
$208.00 |
$521.81 |
| In Buy Zone? |
No
|
Yes
|